×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

GlaxoSmithKline FY’07 net at Rs548 cr

GlaxoSmithKline FY’07 net at Rs548 cr
PTI
Comment E-mail Print Share
First Published: Fri, Feb 22 2008. 03 20 PM IST
Updated: Fri, Feb 22 2008. 03 20 PM IST
Mumbai: GlaxoSmithKline Pharmaceuticals on Friday announced a net profit of Rs547.55 crore for the financial year ended 31 December, 2007, as against a net profit of Rs551 crore in the corresponding period in 2006.
The total income of the group rose to Rs1,701.08 crore in FY’07 from Rs1,652.47 crore in the year-ago period, the company said in a filling to the Bombay Stock Exchange.
The board has recommended a dividend of Rs18 on shares of Rs10 each of the company and has also declared an additional special dividend of Rs18 per share.
The company announced a stand alone net profit of Rs537.66 crore for the financial year ended 2007, as against a net profit of Rs545.51 crore in the corresponding period last year.
The standalone total income of the company rose to Rs1,666.98 crore in FY’07 from Rs1,622.85 crore in the year-ago period.
The company had sold its fine chemicals business last year and animal health business in 2006. Hence, the results of the period are not comparable with the corresponding ones, the company said.
The company announced a standalone net profit of Rs80.90 crore for the fourth quarter of FY’07 as against a net profit of Rs67.79 crore in the fourth quarter of FY’06.
The standalone total income of the firm rose to Rs367.94 crore in the fourth quarter of FY’07 from Rs342.43 crore in the corresponding period previous year.
Shares of the firm were trading at Rs943.20, up 1.05% in the afternoon trading session on the BSE.
Comment E-mail Print Share
First Published: Fri, Feb 22 2008. 03 20 PM IST